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Abstract
Background: To develop the Chinese version of quality of life scale for dry eye patients based on the Impact of
Dry Eye on Everyday Life (IDEEL) questionnaire and to assess the reliability and validity of the developed scale.
Methods: The original IDEEL was adapted cross-culturally to Chinese language and further developed following
standard procedures. A total of 100 Chinese patients diagnosed with dry eye syndrome were included to
investigate the psychometric properties of the Chinese version of scale. Psychometric tests included internal
consistency (Cronbach’s ɑ coefficients), construct validity (exploratory factor analysis), and known-groups validity
(the analysis of variance).
Results: The Chinese version of Dry Eye Related Quality of Life (CDERQOL) Scale contains 45 items classified into
5 domains. Good to excellent internal consistency reliability was demonstrated for all 5 domains (Cronbach’s ɑ
coefficients range from 0.716 to 0.913). Construct validity assessment indicated a consistent factorial structure of the
CDERQOL scale with hypothesized construct, with the exception of “Dry Eye Symptom-Bother” domain. All domain
scores were detected with significant difference across three severity groups of dry eye patients (P < 0.05) except
for “Satisfaction with Treatment” domain, indicating good known-groups validity.
Conclusions: The results indicated that the CDERQOL scale is a reliable and valid instrument for patients with dry
eye syndrome among Chinese population, and could be used as a supplementary diagnostic and treatment-
effectiveness measure.
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Background
Dry eye syndrome is a relatively common disease of the
tear film and ocular surface that results in eye discom-
fort, visual disturbance, and often ocular surface damage
[1, 2]. Previous researches showed dry eye syndrome has
long been prevalent in Chinese population [3, 4]. A
recently published meta-analysis showed the pooled
prevalence of dry eye syndrome in mainland of China
was 17.0%, among which female and elder individuals
were more likely to suffer [5]. The current therapeutic
options are largely symptomatic, including artificial tear
substitutes, or occlusion of the tear drainage. These
treatment modalities give satisfactory results in mild
cases. However, they seem to be insufficient in severe
cases. Severe dry eye could cause corneal ulceration,
opacification, even blindness. Microvascular autologous
transplantation of the submandibular gland (SMG) has
been suggested to be an effective treatment for severe
cases of dry eye syndrome [6–9].
Due to its symptom-based nature, dry eye syndrome
could have detrimental effects on patients’ health-related
quality of life (HRQL) [10]. In this regard, it seems to be
necessary that the diagnosis and evaluation of the sever-
ity of the disease depend not only on objective clinical
tests, but also assessments of perceived symptoms, as
well as patients’ quality of life [11, 12]. There has been
only a few well-developed quality of life scales specific
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on dry eye patients [13], including the Ocular Surface
Disease Index (OSDI) [14], the Impact of Dry Eye on
Everyday Life (IDEEL) questionnaire [15], and a newly
developed single-item questionnaire named the University
of North Carolina Dry Eye Management Scale (UNC
DEMS) [16]. Among these dry eye scales, the IDEEL is
considered to be a reliable and validated questionnaire
that fully assesses symptoms together with the effect of
dry eye on daily life. The IDEEL generated in American
English contains 57 items organized into 3 modules, cov-
ering 6 relevant domains which are Dry Eye Symptom
Bother, Dry Eye Impact on Daily Life (impact on daily
activities, emotional impact due to dry eye, impact on
work due to dry eye), and Dry Eye Treatment Satisfaction
(satisfaction with treatment effectiveness and treatment-
related bother/inconvenience) [15].
Nevertheless, no dry eye-specific quality of life scale
has been developed in China yet that aims to assess the
severity of dry eye syndrome and to evaluate the clinical
effects of surgical treatment for severe dry eye patients.
Therefore, the purpose of this study was to develop a
Chinese version of quality of life scale for dry eye
patients based on the IDEEL questionnaire and to assess
the reliability and validity of the developed scale.
Methods
Study population
Participants were recruited between December 2013
and July 2015 in two specialist hospitals in Beijing,
China. Patients’ dry eye status was evaluated by an
ophthalmologist using the Schirmer test, break-up
time, rose bengal staining and fluorescence staining
[6]. After confirmed diagnosis of dry eye syndrome,
patients were asked to complete a self-administered
questionnaire to test the pilot version of the dry eye
scale under the direction of a trained research assist-
ant. For those who did not have enough time or
those who had vision defect, telephone interviews
were conducted instead during the routine follow-up
check by the attending physicians.
Inclusion criteria were: adult subjects ≥18 years, par-
ticipation on voluntary basis, literate in Chinese. Patients
were excluded from the study if they were diagnosed
with Sjögren syndrome, or if they had other severe dis-
eases that may influence their quality of life substantially,
such as cancer or stroke.
Ethical approval
The study was approved by the Institutional Review
Board of the Peking University Health Science Center
(No. IRB00001052–08048). All of the participants signed
an informed consent form prior to the study.
Translation and development of the scale
The procedure of scale development was shown in
Fig. 1. A standard forward-backward procedure was
used for the translation of original questionnaire. First,
two forward translators independently translated the
IDEEL questionnaire into Chinese (initial Version 1.0 with
57 items), and then two backward translators translated it
back into English in order to maintain accuracy between
the two languages and achieve equivalence between
resource and target questionnaires [17]. The researchers
contacted a professional translation agency to choose
those four translators. All of the translators were native
speakers of Chinese who are fluent in English and also
familiar with medical terminology. The researchers com-
pared two translation and discussed with the translators
for consensus.
In order to achieve cross-culture adaptation [17], we
further conducted three focus group interviews with six
patients with severe dry eye syndrome in each group. A
topic guide was used for the semi-structured interviews,
which included three main questions: (1) what are the
symptoms of dry eye bothering you? (2) what are the
impact of dry eye on your daily life? (3) Do you feel
satisfied with the treatment and why? Interviews were
transcribed into text and data were coded and analyzed
by two experienced qualitative researchers of the team
using thematic framework approach [18]. A thematic
framework was used for coding (Table 1). New emerging
themes from the interviews were added in order to
achieve completeness and comprehension of the ques-
tionnaire for next stage work. Those items not relevant
in Chinese context were deleted. Eventually, we got an
82-item Version 2.0 scale.
Fig. 1 The developing procedure of the CDERQOL scale
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Later two ophthalmologists, three stomatologists and
one public health expert were invited to further adjust
the scale domains and revise the items. As a result, 30
items were deleted, 5 items were combined, 16 items
were revised in wording and 3 items were moved to
other domains, which turned into scale Version 3.0.
Lastly, Delphi inquiry method was used to collect both
qualitative and quantitative assessments from 30 experts
of ophthalmology (10), stomatology (10) and public
health (10). We asked experts to rate each item from
Version 3 a score between 1 to 5 according to its com-
prehensiveness and clarity. We also invited them to give
suggestions for further modification. Finally, several add-
itional deletions and additions were made, yielding pilot
scale Version 4.0, which was used to assess scale’s
reliability and validity.
The pilot Chinese version of Dry Eye Related Quality
of Life (CDERQOL) Scale contains 45 items classified
into 5 domains: Dry Eye Symptom Bother (12 items),
Dry Eye Impact on Daily Life (impact on daily activ-
ities, 7 items; emotional impact, 10 items; impact on
work, 7 items), and Satisfaction with Treatment (9
items). Each item was measured using a 5-point
Likert scale ranging from “completely disagree” (1) to
“completely agree” (5) [19, 20].
Statistical analysis
We first described the sex and age distributions of study
population, and examined differences of sex and age-
group proportions across three dry-eye severity groups
using chi-square tests. Then we evaluated the reliability
and validity of the scale using multiple psychometric
properties and tests. In detail, the construct validity was
evaluated using exploratory factor analysis (EFA), which
combined principal components analysis (PCA) with
promax rotation analysis to testify the conceptual frame-
work and item-dimension structures of the scale. In
order to test whether the data was suitable for factor
analysis, the Kaiser-Meyer-Olkin Measure of Sampling
Adequacy test and the Bartlett test of sphericity were
conducted before we performed EFA. Factors were
retained if their eigenvalues were above 1.0 or according
to the scree plot, and in combination with the theoret-
ical structure of the scale. We considered item loadings
satisfactory if loadings were above 0.40 with their own
factor and larger than loadings with other factors [21].
The internal consistency reliability was assessed using
Cronbach’s ɑ coefficients. The analysis of variance
(ANOVA) was then conducted to evaluate the known-
groups validity, which means to test for differences in
domain scores among patients with different levels of
dry eye severity. We also performed post-hoc pairwise
comparisons using Least Significant Difference tests.
Statistical analysis was performed using PASW Statistics
18 (SPSS, Chicago, IL). Where applicable, a P value of less
than 0.05 was considered statistically significant.
Results
Study population demographics
The initial sample size was 100. After exclusion of missing
data or abnormal value, 90 subjects remained in the ana-
lyses. The demographic characteristics of the study partici-
pants are presented in Table 2.
Among the 90 participants, 60 were diagnosed with
“mild or moderate dry eye syndrome”, while 30 with
“severe dry eye syndrome”. Among the 30 severe patients,
the etiologies were Stevens–Johnson syndrome in 25
patients, acute conjunctivitis in 3 patients, corneal pem-
phigoid in 1 patient, corneal chemical burns in 1 patient,
and unknown in 4 patients.
The majority of the population was female (71.7%) and
the mean age was 50.0 ± 13.8 years (range: 20–70 years
old). Results of chi-square tests showed that the “severe
dry eye” group was significantly younger than both “mild
dry eye” and “moderate dry eye” groups, while the “mild”
and “moderate groups” did not differ significantly by
age. As for sex, the “severe group” contained a signifi-
cantly higher proportion of male subjects (53.6%) than
the other two groups, while the “mild” and “moderate
groups” did not differ significantly by sex.
Psychometric validation of the scale
Construct validity
Given that three modules of “Dry Eye Symptom Bother”,
“Dry Eye Impact on Daily Life” and “Satisfaction with
Treatment” belong to different concepts [22, 23], it was
hypothesized that each module could develop its own
set of items and be considered as distinct sub-scales
[15]. Therefore, we conducted factor analysis of each
module separately.
The three domains of Impact on Daily Activities, Emo-
tional Impact and Impact on Work set up the “Dry Eye
Impact on Daily Life” module. Results of the Kaiser-
Meyer-Olkin Measure of Sampling Adequacy test and the
Bartlett test of sphericity indicated that the data was suit-
able for factor analysis (KMO = 0.840; Bartlett = 1527.1,
Table 1 Coding thematic framework for interviews
1. Physical discomfort caused by dry eye
2. Impact of dry eye on daily life
2.1 impact on daily activities
2.2 emotional impact
2.3 impact on work
3. Satisfaction with treatment
3.1 satisfaction with the result of treatment
3.2 Inconvenience of treatment
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P < 0.001). We then conducted the factor analysis using
PCA method and obtained 5 eigenvalues >1. But according
to the scree plot, it was reasonable to extract 3 common
factors, of which the accumulated variance contribution
rate was up to 59.6% (Table 3).
We further conducted promax rotation analysis to
distinguish the 3 common factors. The results showed
that most items of Emotional Impact could be explained
by factor 1, all items of Impact on Work could be
explained by factor 2, and most items of Impact on Daily
Activities could be explained by factor 3, which suggested
that the construct validity for the “Dry Eye Impact on
Daily Life” module was good (Table 4). Although several
items didn’t load well on their own factors or loaded high
on more than one factor, we didn’t make further adjust-
ments to items so as to retain comparability with the
original scale.
For “Dry Eye Symptom Bother” module, the results sug-
gested 2 dimensions, which was not quite consistent with
the theoretical conceptual framework. The accumulated
Table 2 Demographic characteristics of the study population (N = 90)
Characteristics Severity of dry eye patients, n (%)a χ2 value P value
Mild (n = 24) Moderate (n = 36) Severe (n = 30)
Age < 35 2 (8.3) 10 (27.8) 16 (66.7) 21.915 < 0.001
[35,55) 8 (33.3) 9 (25.0) 6 (25.0)
≥ 55 14 (58.3) 17 (47.2) 2 (8.3)
Sex Male 7 (29.2) 10 (27.8) 15 (53.6) 5.267 0.072
Female 17 (70.8) 26 (72.2) 13 (46.4)
aSome variables contained missing values, thus the proportion in bracket () was valid proportion; severity groups were classified according to clinical diagnosis
Table 3 Eigenvalues of the common factors and total variance explained
Components Extraction sums of squared loading Rotation sums of squared loading
Eigenvalue Variance
contribution rate, %
Accumulated variance
contribution rate, %
Eigenvalue Variance
contribution rate, %
Accumulated variance
contribution rate, %
1 10.34 43.07 43.07 5.09 21.22 21.22
2 2.33 9.72 52.79 4.82 20.08 41.30
3 1.64 6.82 59.61 4.40 18.32 59.61
4 1.33 5.55 65.16
5 1.06 4.41 69.58
6 0.96 3.99 73.56
7 0.80 3.35 76.91
8 0.75 3.11 80.02
9 0.66 2.76 82.78
10 0.60 2.50 85.28
11 0.53 2.22 87.50
12 0.47 1.95 89.45
13 0.42 1.74 91.19
14 0.35 1.46 92.65
15 0.32 1.34 93.99
16 0.27 1.14 95.13
17 0.23 0.95 96.08
18 0.22 0.93 97.00
19 0.19 0.78 97.78
20 0.17 0.71 98.50
21 0.12 0.52 99.01
22 0.11 0.47 99.48
23 0.08 0.34 99.82
24 0.04 0.18 100.00
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variance contribution rate of the 2 factors was only
45.0%. The results are presented in (Additional file 1:
Tables S1 and S2).
The “Satisfaction with Treatment” module yielded 2
distinct factors with eigenvalues >1, of which the accu-
mulated variance contribution rate was up to 60.1%, in-
dicating a structure of 2 dimensions. The dimensions
could be clinically interpreted as Satisfaction with
Treatment Effectiveness and Satisfaction with Tear
Amount. The results are presented in (Additional file 1:
Tables S3 and S4).
Internal consistency reliability
The internal consistency reliability of the scale is pre-
sented in Table 5. The internal consistency reliability
was acceptable in all 5 domains (Dry Eye Symptom
Bother, Impact on Daily Activities, Emotional Impact,
Impact on Work and Satisfaction with Treatment),
with the Cronbach’s ɑ coefficients ranging from 0.716
to 0.913.
Known-groups validity
The mean scores of all domains were found significantly
different across three dry-eye severity levels (P < 0.001),
except for the domain of Satisfaction with Treatment
(Table 6). Results of pairwise comparisons showed that
for domains of Dry Eye Symptom Bother and Impact on
Daily Activities, the scores of mild and moderate pa-
tients group both differed significantly from that of the
severe group (P < 0.05). As for domains of Emotional
Impact and Impact on Work, all pairwise comparisons
between the three severity groups resulted in P < 0.05.
The results suggested the known-groups validity of the
CDERQOL scale was good.
Discussion
This study is one of the first studies that targeted at devel-
opment and validation of the Chinese version of quality of
life scale among dry eye patients. We have fulfilled the
translation and cross-cultural adaptation of the widely-
used IDEEL questionnaire. The results of psychometric
analyses showed that the CDERQOL scale obtained good
reliability and validity among Chinese dry eye patients.
In contrast to the IDEEL, the CDERQOL scale was de-
veloped based on the symptom complaints and life qual-
ity situation of Chinese patients, and emphasized more
on the severe group of patients. In consideration of the
severe patients’ symptoms and feelings, we added spe-
cific items such as “Vision loss”, “Little or no tears when
crying” and “Lose confidence in treatment”. Moreover,
the items “Afraid of economic burden of the treatment
for dry eye” and “Afraid of trouble brought to your fam-
ily members” were added in consideration of social-
support for dry eye patients. Since more patients in
China are in or over their middle ages than in other
countries [5], we deleted the items of “Wearing contact
lenses” and “Wearing make-up near or on my eyes” in
the original IDEEL according to the Chinese patients’
daily lifestyle and social context. We also replaced the
item “Working on a computer” with “Watching TV for a
long time” because computers have not yet been widely
used in some parts of China, especially in rural areas.
When we interviewed Chinese patients and experts, we
Table 4 Rotated factor matrix of the Dry Eye Impact on Daily
Life module (promax method)
Domains Items Factors
1 2 3
Impact on Daily Activities B1 0.363 0.401 0.139
B2 0.217 −0.157 0.686
B3 0.225 0.440 0.471
B4 0.244 0.288 0.758
B5 −0.024 0.148 0.756
B6 0.261 0.367 0.405
B7 0.389 0.286 0.600
Emotional Impact C1 0.659 0.243 0.284
C2 0.734 0.346 0.199
C3 0.624 0.316 0.273
C4 0.805 0.039 0.463
C5 0.389 0.532 −0.008
C6 0.369 0.441 0.440
C7 0.739 0.059 0.546
C8 0.701 0.310 0.079
C9 0.789 0.220 0.185
C10 0.449 0.074 0.632
Impact on Work D1 0.191 0.782 0.232
D2 0.020 0.841 0.114
D3 0.214 0.766 0.243
D4 0.370 0.462 0.154
D5 0.301 0.586 0.497
D6 0.286 0.579 −0.273
D7 0.179 0.640 0.448
Note: values in boldface indicate the highest factor loading of the item
Table 5 Internal consistency properties (Cronbach’s ɑ
coefficients) of the CDERQOL scale
Domains Number of items Cronbach’s
ɑ coefficients
Dry Eye Symptom Bother 12 0.826
Impact on Daily Activities 7 0.811
Emotional Impact 10 0.913
Impact on Work 7 0.865
Satisfaction with Treatment 9 0.716
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realized few reported “Headaches associated with dry
eye symptoms” and the emotion of “Feeling older than I
really are”, so we deleted the items based on the infor-
mation from focus group interviews with patients and
expert consultation.
The reliability analyses performed in this study indi-
cated the CDERQOL scale has high internal consistency
within all 5 domains, which is consistent with the
original IDEEL. To be noted, the Cronbach’s ɑ coeffi-
cients demonstrated relatively low reliability of the
domain “Satisfaction with Treatment”, with similar
results also found in IDEEL [15]. This may be due to the
relatively distinct aspects of items in this domain. How-
ever, the coefficients we got all surpassed the empirical
reliability criterion of 0.70 [24, 25], which confirmed
strong internal reliability of the scale.
As for the validity assessment, the construct validity
results of the CDERQOL scale were basically consistent
with the hypothesized conception structure except for
the “Dry Eye Symptom Bother” domain. The factor ana-
lysis results indicated two dimensions for “Dry Eye
Symptom Bother”. But the two factors only accounted
for 45.0% of the total variance, which means they cannot
fully represent or explain the whole set of items, thus
need further investigation. Same with the IDEEL, “Satis-
faction with Treatment” domain yielded two distinct fac-
tors, but we focused more on “Satisfaction with Tear
Amount” after the treatment instead of the “Treatment-
Related Bother/Inconvenience” in the original IDEEL
questionnaire.
The known-groups validity of all domains was good
except for the domain of “Satisfaction with Treatment”.
This is highly understandable because there are cur-
rently limited treatment methods for dry eye syndrome
and treatment effects have not been confirmed yet. Thus
there could be little difference of the treatment satisfac-
tion among different severity groups of patients.
The current study still has several limitations. First of all,
the sample size for psychometric validation was relatively
small due to practical difficulties in recruiting eligible dry
eye patients in hospitals, which could possibly compromise
our results. However, some studies demonstrated that
parametric statistics remain robust even with small sample
size in the psychometric analysis [26]. Secondly, instead of
in-person interview, a few patients in our study were inter-
viewed through telephone due to realistic conditions,
which could possibly lead to information bias [27]. There
also remains a methodology problem questioning whether
it is appropriate to use parametric methods (such as
ANOVA and EFA conducted above) to analyze ordinal
Likert Scale data. In fact, there is still a lot of discussion on
this topic [26, 28]. Moreover, some researches indicated
Likert scale could be biased under different cultural back-
ground and has so-called “reference-group effect” [29–31],
which were not detected in this study. Finally, after the
process of cross-cultural adaptation and item modification,
the Chinese version of scale may not be reliably compar-
able with the original version, although most of the items
overlap between the two versions.
In light of next steps, further research into the com-
parability between the Chinese version of dry eye scale
and original IDEEL is warranted. Moreover, as the
Chinese population is experiencing dramatic change in
lifestyle and social context, some items of the scale may
not be suitable in the future. Therefore, future research
is needed to evaluate the content validity of the scale.
Besides of the psychometric properties assessed in this
study, several other properties merit further investiga-
tion, such as test-retest reliability, concurrent validity
and responsiveness. Furthermore, it is worth consider-
ation to combine the CDERQOL scale with clinical tests
of dry eye syndrome in clinical research.
Conclusions
The CDERQOL scale we developed in this study has
been proved to be a reliable and valid instrument for the
measurement of Quality of Life of Chinese dry eye pa-
tients. The scale could have various applications including
diagnosis and severity assessment of dry eye syndrome, as
well as the evaluation of treatment effectiveness among
dry eye patients.
Table 6 Known-groups validity of the CDERQOL scale by dry eye severity
Domain scores x

(s) Severity of dry eye* F value P value
Mild (n = 24) Moderate (n = 36) Severe (n = 30)
Dry Eye Symptom Bother 32.7 (8.4) 35.3 (9.8) 44.1 (9.0)b,c 12.028 < 0.001
Impact on Daily Activities 17.4 (4.6) 19.8 (5.1) 28.8 (3.9)b,c 47.476 < 0.001
Emotional Impact 21.2 (7.5) 25.9 (7.2)a 38.4 (7.5)b,c 40.864 < 0.001
Impact on Work 20.0 (5.8) 23.3 (6.8)a 27.0 (5.9)b,c 8.898 < 0.001
Satisfaction with Treatment 31.3 (6.0) 32.5 (4.5) 30.3 (5.1) 1.333 0.270
*Severity groups were classified according to clinical diagnosis
aP < 0.05 for pairwise comparison between mild and moderate groups
bP < 0.05 for pairwise comparison between mild and severe groups
cP < 0.05 for pairwise comparison between moderate and severe groups
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